AIFAIM
FBLG icon

American Institute for Advanced Investment Management’s FibroBiologics FBLG Stock Holding History

American Institute for Advanced Investment Management’s Portfolio FBLG Stock Details FBLG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-4,410
Closed -$19.8K – 157
2025
Q4 		$19.8K Hold
4,410
– – 0.01% 150
2025
Q3 		$48.2K Hold
4,410
– – 0.03% 147
2025
Q2 		$54.9K Hold
4,410
– – 0.04% 146
2025
Q1 		$79.4K Hold
4,410
– – 0.06% 143
2024
Q4 		$176K Hold
4,410
– – 0.13% 130
2024
Q3 		$273K Hold
4,410
– – 0.2% 116
2024
Q2 		$440K Buy
+4,410
New +$841K 0.34% 77

Other funds holding FBLG

VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
FEG
Fund Evaluation Group Cincinnati, Ohio $3.7B AUM 16.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CFP
Cascade Financial Partners San Diego, California $1.15B AUM 33.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
VGA
Vanguard Global Advisers Malvern, Pennsylvania $187B AUM

American Institute for Advanced Investment Management's FBLG Position: Q1 2026 in Review

American Institute for Advanced Investment Management sold out of FibroBiologics (FBLG) in Q1 2026, closing a stake of 4,410 shares — an estimated $19.8K sold.

American Institute for Advanced Investment Management first reported a position in FBLG in Q2 2024 and held it in 7 quarters. The position peaked at $440K in Q2 2024. 17 funds tracked by Wall St. Rank hold FBLG as of Q1 2026.

  • American Institute for Advanced Investment Management reported no remaining FibroBiologics position as of Q1 2026 after selling out during the quarter.
  • American Institute for Advanced Investment Management sold 4,410 FibroBiologics shares in Q1 2026, an estimated $19.8K.
  • American Institute for Advanced Investment Management first reported a position in FibroBiologics in Q2 2024 and held it in 7 quarters.
  • American Institute for Advanced Investment Management's FibroBiologics position peaked at $440K in Q2 2024.
  • 17 funds tracked by Wall St. Rank held FibroBiologics as of Q1 2026.

Based on American Institute for Advanced Investment Management's 13F filing for Q1 2026, filed 24 Apr 2026.